Adaptive Alzheimer's Disease Treatment Systems for Specialized Environments

Publication ID: 24-11857568_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Alzheimer's Disease Treatment Systems for Specialized Environments,” Published Technical Disclosure No. 24-11857568_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857568_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,568.

Summary of the Inventive Concept

The inventive concept discloses novel systems and methods for treating and preventing Alzheimer's disease in specialized environments, such as high-security facilities, disaster relief areas, extreme weather conditions, isolated areas, and for patients with compromised immune systems.

Background and Problem Solved

The original patent disclosed methods for treating and preventing Alzheimer's disease using aluminum salts. However, these methods did not address the unique challenges and requirements of specific environments and patient populations. The new inventive concept addresses these limitations by providing adaptive treatment systems tailored to these niche applications.

Detailed Description of the Inventive Concept

The inventive concept comprises four main components: (1) a pharmaceutical formulation comprising an aluminum salt in an amount from about 1.0 mg to about 2.0 mg; (2) a system or method designed to operate in a specific environment, such as high-security facilities, disaster relief areas, extreme weather conditions, or isolated areas; (3) optional additional features, such as emergency response training, weather-resistant containers, or wearable devices for tracking cognitive function; and (4) a communication module for transmitting tracked data to a remote monitoring center. These components work together to provide effective treatment and prevention of Alzheimer's disease in specialized environments.

Novelty and Inventive Step

The new claims introduce novel and non-obvious adaptations of the original patent's methods to address the unique challenges of specialized environments and patient populations. The inventive concept's combination of a pharmaceutical formulation with environment-specific design elements and optional additional features constitutes a significant departure from the prior art.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the pharmaceutical formulation, such as different dosages or combinations of active ingredients. Additionally, the system or method could be adapted for use in other specialized environments, such as military operations or space exploration.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare and pharmaceutical industries, particularly in the areas of geriatric care, disaster relief, and extreme environment operations. The target market includes healthcare providers, pharmaceutical companies, and government agencies responsible for disaster relief and emergency response.

Original Patent Information

Patent NumberUS 11,857,568
TitleTreatment and prevention of Alzheimer's disease (AD)
Assignee(s)Advantage Therapeutics, Inc.